EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial-Reference-Cited by-同舟云学术

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Published:2014-05 Issue:9929 Volume:383 Page:1637-1647
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rice Andrew S C,Dworkin Robert H,McCarthy Tom D,Anand Praveen,Bountra Chas,McCloud Philip I,Hill Julie,Cutter Gary,Kitson Geoff,Desem Nuket,Raff Milton

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. International union of pharmacology. XXIII. The angiotensin II receptors;de Gasparo;Pharmacol Rev,2000

2. A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site;VanAtten;J Med Chem,1993

3. Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons;Anand;Eur J Pain,2013

4. A small molecule angiotensin II type 2 receptor (AT2 R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia;Smith;Pain Med,2013

5. Small molecule angiotensin II type 2 receptor (AT2, R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats;Smith;Pain Med,2013

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable, reversibly thermoresponsive captopril-laden hydrogel for the local treatment of sensory loss in diabetic neuropathy;Scientific Reports;2024-08-16

2. Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review;Cancer Chemotherapy and Pharmacology;2024-06-25

3. Novel drugs affecting diabetic peripheral neuropathy;IRAN J BASIC MED SCI;2024

4. N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands;European Journal of Medicinal Chemistry;2024-02

5. Diabetic Neuropathy;Textbook of Diabetes;2024-01-12